EichorEICHOR
Location: Canterbury Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Canterbury

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · East Kent Hospitals University NHS Foundation Trust · Hoffmann-La Roche · NCT06793215Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832Study of Student Flourishing
NA · Flourish Science, Inc. · NCT07259746A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Merck Sharp & Dohme LLC · NCT06077760A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Kent & Canterbury Hospital, Canterbury · Takeda · NCT06963827A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Pfizer · NCT06629779A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Ipsen · NCT06016842GEKO Venous Thromboembolism Prevention Study
NA · Kent and Canterbury Hospital · Firstkind Ltd · NCT05476913A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Kent and Canterbury Hospital · Dimerix Bioscience Pty Ltd · NCT05183646A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alo
Phase 1 · AbbVie · NCT07278336Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · Queen Elizabeth The Queen Mother Hospital · University of Leeds · NCT04102930Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Phase 3 · Kent and Canterbury Hospital · Iperboreal Pharma Srl · NCT03994471Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
Phase 2 · Kent & Canterbury Hospital · Royal Marsden NHS Foundation Trust · NCT06250036A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Kent and Canterbury Hospital · Janssen Research & Development, LLC · NCT07258511Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Merck Sharp & Dohme LLC · NCT03486873LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Boehringer Ingelheim · NCT06632457HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's
Phase N/A · University College, London · NCT02855476A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Kent and Canterbury Hospital · Janssen Research & Development, LLC · NCT05552222A Dose-Escalation Study of RO7875913 in Healthy Participants
Phase 1 · Genentech, Inc. · NCT07342114Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · East Kent Hospitals University NHS Foundation Trust · The University of Queensland · NCT03573089Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to E
Phase 3 · Kent & Canterbury Hospital (East Kent University) · King's College Hospital NHS Trust · NCT04663750A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Hoffmann-La Roche · NCT05878769Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension
Phase 3 · Insmed Incorporated · NCT07179380A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Kent and Canterbury Hospital · Janssen Research & Development, LLC · NCT06852222A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)
NA · Andromeda Surgical · NCT07741656Eating Disorders Genetics Initiative 2
Phase N/A · University of North Carolina, Chapel Hill · NCT06594913MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Kent and Canterbury Hospital · Pfizer · NCT06152575Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Sur
NA · Kent & Canterbury Hospital · Imperial College London · NCT04103372Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · AbbVie · NCT06332534
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.